CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal

CVS Health has overhauled its direct-to-consumer weight management program in a move that puts pharmacists closer to the center of how patients start and stay on glucagon-like peptide-1 (GLP-1) receptor agonist therapy. Announced August 5, 2026, the revamp lowers the cost of an initial clinical visit, adds transparent medication pricing through a new collaboration with Eli Lilly and Company, and connects online care, same-day dispensing, and in-person pharmacist support into a single pathway with no membership or recurring monthly fee.¹

What Changed for Patients

The program combines a virtual visit with a licensed clinician, same-day medication pickup at roughly 9000 CVS Pharmacy locations, and face-to-face pharmacist support. MinuteClinic online weight loss visits now cost $29, available around the clock, which CVS Health describes as the most affordable option in the market. Patients begin with a clinician who reviews their health history and weight management goals before determining whether a GLP-1 receptor agonist is appropriate, and those who start therapy can schedule follow-ups for dose adjustments, adverse effect (AE) support, and monitoring. The service is aimed at self-paying adults aged 18 to 64 years who are overweight or living with obesity and is available nationally in line with state-level regulations.¹

The Eli Lilly Collaboration and Pricing

Under the new collaboration with Eli Lilly, eligible patients prescribed tirzepatide (Zepbound; Eli Lilly) or orforglipron (Foundayo; Eli Lilly) will be able to view transparent pricing—including cash-pay options—in the CVS Health app, with same-day pickup possible at CVS Pharmacy locations. CVS Health said this functionality is expected by early in the fourth quarter of 2026. The company noted that oral and injectable formulations of semaglutide (Wegovy; Novo Nordisk) are already available, positioning CVS Pharmacy as a destination for all FDA-approved GLP-1s regardless of how the prescription is reimbursed.¹

Navigating Cost and Coverage

Cost remains a central barrier, and the announcement leans heavily on the many ways patients pay for these drugs—insurance, cash-pay, manufacturer coupons, vouchers, and third-party discount cards. CVS Health said out-of-pocket cost for a GLP-1 can run as low as $25 a month through commercial insurance with a manufacturer coupon for eligible patients or $149 for those without insurance who use a manufacturer voucher for qualifying medications and doses.¹

CVS Pharmacy also participates in the Centers for Medicare & Medicaid Services (CMS) Medicare GLP-1 Bridge, a time-limited demonstration running July 1, 2026, through December 31, 2027, under which eligible Medicare Part D beneficiaries can access certain GLP-1 medications for $50 per month.^2,3

Where Pharmacists Fit

The company framed pharmacists as central to keeping patients on therapy. Citing its 2025 Rx Report, CVS Health said nearly half of consumers prioritize personalized care at the pharmacy and 80% prefer face-to-face engagement over digital tools, an argument for keeping a pharmacist available in person at 9000 locations at no additional cost. For pharmacists, that positioning translates into a larger counseling role on titration, gastrointestinal AEs, adherence, and helping patients navigate the tangle of payment pathways that determine whether they can afford to continue.^1,4

REFERENCES

1. CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications. News Release. CVS Health. August 5, 2026. Accessed August 7, 2026. https://www.cvshealth.com/news/company-news/cvs-health-enhances-its-direct-to-consumer-weight-management-offerings.html

2. CMS launches Medicare GLP-1 Bridge, expanding access to GLP-1 medications. News Release. Centers for Medicare & Medicaid Services. July 1, 2026. Accessed August 7, 2026. https://www.cms.gov/newsroom/press-releases/cms-launches-medicare-glp-1-bridge-expanding-access-glp-1-medications

3. Medicare GLP-1 Bridge: information for providers. Centers for Medicare & Medicaid Services. Updated August 6, 2026. Accessed August 7, 2026. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers

4. The Rx Report: Community pharmacy reimagined. CVS Health. Fall 2025. Accessed August 7, 2026. https://www.cvshealth.com/news/insights-innovations/rx-report.html